Science & Enterprise subscription

Follow us on Twitter

  • Symptom checker K Health raises $48M https://t.co/hIEK1AL5vd
    about 23 hours ago
  • This makes me feel better ... Pence Will Control All Coronavirus Messaging From Health Officials https://t.co/M2Fv13okyE
    about 2 days ago
  • https://t.co/8n5kpVEGCH
    about 2 days ago
  • Takeda acquires PvP Biologics for $330M following Phase I celiac disease study results https://t.co/Amtm5sS9aq
    about 2 days ago
  • https://t.co/mZ8yGjsAgx Raises $462M With Toyota In The Driver’s Seat https://t.co/8gawjBxZzw via @crunchbasenews
    about 3 days ago

Please share Science & Enterprise

Biotech Partnership to Develop Non-Ricin Castor Plants

Castor beans

Castor beans (plants.usda.gov)

12 March 2014.  Precision BioSciences Inc. and Novo Synthetix, biotechnology companies in Durham, North Carolina, are collaborating on a new type of castor bean, without the ricin poison that makes the beans difficult to process and market. Financial and intellectual property aspects of the deal were not disclosed.

Beans from castor plants (Ricinus communishave the potential to become a rich source of industrial oils, plastics, chemicals, and biofuels, particularly as a renewable feedstock and additional cash crop for farmers. In September 2013, Evogene Ltd., an Israeli agricultural biotechnology company and SLC Agricola in Brazil began commercial development of engineered castor beans as an alternative source for biodiesel and other industrial products.

But castor beans are also highly toxic, and the source of ricin,  implicated in the ricin-laced letters sent last year to addresses in Washington, D.C., including the White House. The Centers for Disease Control and Prevention says exposure to even a small amount of ricin can be fatal.

Novo Synthetix is in the business of producing castor beans without ricin. Its strategy is to develop a new variety of castor plant, but without the introduction of alien genes, thus avoiding the label of a genetically-modified plant, which would make it more difficult to market in the U.S. and Europe.

Under the deal, Novo Synthetix will employ gene-editing technology from Precision BioSciences to create the non-ricin castor plant, yet still be considered non-genetically modified. Precision BioSciences uses enzymes it developed to alter natural genetic sequences. The company says its technology makes it possible to insert new genes into the sequence, or deactivate or remove unwanted genes. In addition, the technology can excise unwanted smaller genetic fragments rather than entire genes.

Novo Synthetix was founded in 2012 and received a $50,000 loan from the North Carolina Biotechnology Center in 2013. The company won last year’s Ag Biotech Entrepreneurial Showcase put on by North Carolina Biotechnology Center.

Read more:

*     *     *

Please share Science & Enterprise ...

Comments are closed.